T1	Protein 839 842	IgG
T2	Protein 990 1003	interleukin-6
T3	Protein 1005 1009	IL-6
T4	Protein 1015 1036	von Willebrand factor
T5	Protein 1038 1041	vWF
T6	Protein 1210 1243	vascular cell adhesion molecule 1
T7	Protein 1245 1278	intercellular adhesion molecule 1
T8	Protein 1284 1294	E-selectin
T9	Protein 1831 1834	IgG
T10	Protein 1929 1933	IL-6
T11	Protein 1938 1941	vWF
T43	Exp 152 195	monoclonal anti-endothelial cell antibodies
T44	Exp 767 772	mAECA
R4	Coref Anaphora:T15 Antecedent:T43
R5	Coref Anaphora:T17 Antecedent:T44
R6	Coref Anaphora:T29 Antecedent:T30
T15	Exp 255 268	their ability
T16	Exp 349 362	the mechanism
T17	Exp 774 779	which
T18	Exp 740 765	the monoclonal antibodies
T19	Exp 786 825	the same EC epitope binding specificity
T20	Exp 829 847	the total IgG-AECA
T21	Exp 853 883	the Takayasu arteritis patient
T22	Exp 885 896	The binding
T23	Exp 900 909	the mAECA
T24	Exp 966 986	The secretion levels
T25	Exp 1099 1115	The activated EC
T26	Exp 1134 1147	the adherence
T27	Exp 1329 1349	the mAECA-treated EC
T28	Exp 1368 1381	the induction
T29	Exp 1568 1573	which
T30	Exp 1553 1564	the mixture
T31	Exp 1613 1629	the original IgG
T32	Exp 1636 1647	the patient
T33	Exp 1799 1808	The mAECA
T34	Exp 1879 1890	the 6 mAECA
T35	Exp 1953 1964	The 4 mAECA
T36	Exp 2099 2124	the nuclear translocation
T37	Exp 2128 2162	the NF-kappaB transcription factor
T38	Exp 2076 2087	these mAECA
T39	Exp 2176 2188	Our findings
T40	Exp 2197 2201	that
T41	Exp 2413 2428	the development
T42	Exp 2432 2448	the vasculopathy
